Project Grant R21CA290137
Award Date
5/1/24
Completion Date
5/28/24
Dollars Obligated
$371K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19122, USA
Similar Awards
This federal Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) will support research at the University of Texas MD Anderson Cancer Center to study the cellular and genetic mechanisms of esophageal squamous cell carcinoma (ESCC) initiation. The award, totaling $128,936, will fund a 2-year research project to comprehensively analyze ESCC preneoplastic cells using single-cell RNA sequencing data from human and mouse models. Key objectives...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $415,257 to the University of Virginia to conduct research aimed at identifying epigenetic and transcriptomic drivers of racial disparities in colorectal cancer risk and site-specific tumor development. The key products and services to be delivered under this 2-year award include: Identifying site-specific DNA methylation-associated gene expression signatures across different...
This Project Grant awarded by the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) to Emory University provides $659,498 in funding to investigate racial disparities in the mechanisms of prostate cancer metastasis. The research aims to analyze differential pathway activity, particularly related to the FGFR3 signaling and oxidative phosphorylation (OXPHOS) pathways, and their impact on metastasis in African American men. The project will leverage in vitro and in vivo models, as...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), will support research conducted by Thomas Jefferson University to investigate genomic factors contributing to racial disparities in metastatic prostate cancer outcomes. The key products or services to be delivered under this $156,000 award include whole-exome sequencing of circulating tumor cells (CTCs) from paired Black and White patients with metastatic...
This $659,936 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), will support a comprehensive study on racial disparities in oral cavity squamous cell carcinoma (OSCC) outcomes. The University of Maryland, Baltimore will conduct multi-scale analyses to evaluate biological, imaging, and socioeconomic factors driving survival differences between African American and...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $1,623,261 to Case Western Reserve University to conduct a clinical trial on early detection and intervention for esophageal adenocarcinoma (EAC), a cancer with 80% 5-year mortality. The key goals are to: 1) Demonstrate the efficacy of a non-endoscopic, biomarker-based approach to detect Barrett's esophagus (BE), the precursor to EAC, in patients without symptoms of...
This Project Grant award of $1,614,573.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research conducted by The Trustees of the University of Pennsylvania to investigate the molecular drivers underlying the transition from non-dysplastic to dysplastic Barrett's esophagus. The researchers will leverage single-cell RNA sequencing and mitochondrial mutation-based lineage tracing...
This $399,187 federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support research at Virginia Commonwealth University to study the role of ATG16L1 isoforms in colorectal cancer health disparities. The key objectives are to: 1) Determine whether the ATG16L1 T300T isoform, which is more predominant in African Americans, promotes more aggressive colorectal tumor growth and metastasis compared to the A300A isoform found more in...
This federal Project Grant award of $622,003 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to characterize the role of pathogenic germline mutations in the progression of Barrett's esophagus to esophageal adenocarcinoma. The award aims to provide more precise risk estimates of germline alterations in the ATM and BRCA2 genes, assess the impact of...
The Project Grant award of $300,000.00 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) will support a study on the epidemiology of the gut-liver axis and its relationship to hepatocellular carcinoma (HCC) risk in a multiethnic liver cirrhosis cohort. The study aims to expand the existing Microbiome, Microbial Markers, and Liver Disease (M3LD) cohort by enrolling approximately 1,000 participants with liver cirrhosis, with a focus on...